Of note, we did not observe changes in the expression of proteins from the ERK1/2 pathway in response to depletion or overexpression of Prox1, which suggests that PROX1 is not involved in the regulation of this pathway in follicular thyroid cancer (data not shown). This evidence concerns the gene PROX1 and thyroid gland follicular carcinoma.